|
US7488485B2
(en)
*
|
2003-09-16 |
2009-02-10 |
University Of Kansas Medical Center |
DNA vaccine compositions and methods of use
|
|
GB9711957D0
(en)
*
|
1997-06-09 |
1997-08-06 |
Isis Innovation |
Methods and reagents for vaccination
|
|
US20030138454A1
(en)
*
|
1997-06-09 |
2003-07-24 |
Oxxon Pharmaccines, Ltd. |
Vaccination method
|
|
US6919318B1
(en)
*
|
1998-04-22 |
2005-07-19 |
Chiron Corporation |
Enhancing immune responses to genetic immunization by using a chemokine
|
|
WO1999061049A2
(en)
*
|
1998-05-22 |
1999-12-02 |
University Of Massachusetts Medical Center |
Model for infection by a pathogen using administration of nucleic acids
|
|
US6562800B1
(en)
*
|
1998-10-30 |
2003-05-13 |
University Of Southern California |
Use of immunopotentiating sequences for inducing immune response
|
|
US6759237B1
(en)
*
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
AU780231B2
(en)
*
|
1998-11-10 |
2005-03-10 |
University Of North Carolina At Chapel Hill, The |
Virus vectors and methods of making and administering the same
|
|
PT1141315E
(pt)
|
1998-12-31 |
2008-05-05 |
Novartis Vaccines & Diagnostic |
Polipéptidos do envelope (env) de hiv modificados
|
|
EP1980617A1
(en)
*
|
1998-12-31 |
2008-10-15 |
Novartis Vaccines and Diagnostics, Inc. |
Improved expression of HIV polypeptides and production of virus-like particles
|
|
US7935805B1
(en)
*
|
1998-12-31 |
2011-05-03 |
Novartis Vaccines & Diagnostics, Inc |
Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
|
|
WO2000039304A2
(en)
*
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
|
WO2000044410A2
(en)
*
|
1999-01-28 |
2000-08-03 |
Stichting Biomedical Primate Research Centre |
Composition and method for obtaining specific immunisation against one or more antigens using different recombinant vectors
|
|
DE19907485B4
(de)
*
|
1999-02-12 |
2008-01-17 |
Strathmann Ag & Co. |
Virus-Vakzine
|
|
US6420545B1
(en)
*
|
1999-05-24 |
2002-07-16 |
The Trustees Of The University Of Pennsylvania |
CD4-independent HIV envelope proteins as vaccines and therapeutics
|
|
AU3793701A
(en)
*
|
1999-11-29 |
2001-06-04 |
Orchid Biosciences, Inc. |
Methods of identifying optimal drug combinations and compositions thereof
|
|
US8623379B2
(en)
*
|
2000-03-02 |
2014-01-07 |
Emory University |
Compositions and methods for generating an immune response
|
|
US20040105871A1
(en)
*
|
2000-03-02 |
2004-06-03 |
Robinson Harriet L. |
Compositions and methods for generating an immune response
|
|
CN1311871C
(zh)
|
2000-03-02 |
2007-04-25 |
爱莫里大学 |
Dna表达载体及其应用方法
|
|
EP1311278A4
(en)
*
|
2000-08-07 |
2005-01-05 |
Sloan Kettering Institutefor C |
METHOD AND IMMUNIZATION COMPOSITION USING MIXED POOLS OF NUCLEIC ACIDS OR MUTED PEPTIDES
|
|
AU2002305914A1
(en)
*
|
2001-01-12 |
2002-10-21 |
Chiron Corporation |
Nucleic acid mucosal immunization
|
|
AU2002252199B2
(en)
*
|
2001-03-08 |
2008-01-03 |
Emory University |
MVA expressing modified HIV envelope, GAG, and POL genes
|
|
JP4302513B2
(ja)
|
2001-07-05 |
2009-07-29 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
抗原性ｂ型ｈｉｖポリペプチドおよび／または抗原性ｃ型ｈｉｖポリペプチドをコードするポリヌクレオチド、それらのポリペプチドおよびそれらの使用
|
|
AU2002320314A1
(en)
|
2001-07-05 |
2003-01-21 |
Chiron, Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
|
GB0118532D0
(en)
*
|
2001-07-30 |
2001-09-19 |
Isis Innovation |
Materials and methods relating to improved vaccination strategies
|
|
US20030170614A1
(en)
*
|
2001-08-31 |
2003-09-11 |
Megede Jan Zur |
Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
|
|
JP2005521380A
(ja)
*
|
2001-08-31 |
2005-07-21 |
カイロン コーポレイション |
抗原性ｂ型ｈｉｖポリペプチドをコードするポリヌクレオチド、そのポリペプチドおよびそれらの使用
|
|
US20030228327A1
(en)
*
|
2001-11-05 |
2003-12-11 |
Lasher Alfred W. |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
US20070269456A1
(en)
*
|
2001-11-05 |
2007-11-22 |
Lasher Alfred W |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
EP1450854A2
(en)
|
2001-11-30 |
2004-09-01 |
Isis Innovation Limited |
Vaccine
|
|
US7094410B2
(en)
*
|
2002-03-02 |
2006-08-22 |
The Scripps Research Institute |
DNA vaccine against proliferating endothelial cells and methods of use thereof
|
|
US6923958B2
(en)
*
|
2002-03-02 |
2005-08-02 |
The Scripps Research Institute |
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
|
|
US20040106566A1
(en)
*
|
2002-05-17 |
2004-06-03 |
Shi-Lung Lin |
RNA-splicing and processing-directed gene silencing and the relative applications thereof
|
|
EP2316479B8
(en)
*
|
2002-07-18 |
2015-03-18 |
University of Washington |
Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
|
|
EP1578766B1
(en)
*
|
2002-12-03 |
2013-02-13 |
University of Massachusetts |
Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
|
|
MXPA05012270A
(es)
*
|
2003-05-12 |
2006-02-10 |
Univ Florida |
Materiales y metodos para inmunizar en contra de la infeccion por virus de inmunodeficiencia de felino.
|
|
US7658927B2
(en)
*
|
2003-05-12 |
2010-02-09 |
University Of Florida Research Foundation, Inc. |
Materials and methods for immunizing against FIV infection
|
|
US8076060B2
(en)
*
|
2003-08-04 |
2011-12-13 |
Emil William Chynn |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
|
|
WO2005023313A1
(en)
*
|
2003-09-09 |
2005-03-17 |
Virxsys Corporation |
Lentivirus vector-based approaches for generating an immune response to hiv humans
|
|
EP1675613B1
(en)
|
2003-09-15 |
2012-05-23 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Hiv vaccines based on env of multiple clades of hiv
|
|
EP1667631A4
(en)
*
|
2003-09-15 |
2010-04-14 |
Novartis Vaccines & Diagnostic |
COMBINATION PATHS FOR GENERATING IMMUNE RESPONSES
|
|
US20050175627A1
(en)
*
|
2003-09-24 |
2005-08-11 |
Oxxon Therapeutics Ltd. |
HIV pharmaccines
|
|
US7622125B2
(en)
|
2004-05-05 |
2009-11-24 |
Novartis Vaccines And Diagnostics, Inc. |
Polycistronic HIV vector constructs
|
|
AU2005249450A1
(en)
*
|
2004-05-27 |
2005-12-15 |
Centocor, Inc. |
Cynomolgus prostate specific antigen
|
|
WO2006101503A2
(en)
*
|
2004-06-15 |
2006-09-28 |
Centocor, Inc. |
Method for screening agents against human prostate disease
|
|
AU2005274948B2
(en)
*
|
2004-07-16 |
2011-09-22 |
Genvec, Inc. |
Vaccines against aids comprising CMV/R-nucleic acid constructs
|
|
US20080085261A1
(en)
*
|
2004-10-19 |
2008-04-10 |
Haynes Barton F |
Vaccine Adjuvant
|
|
US20100015211A1
(en)
*
|
2004-11-01 |
2010-01-21 |
Barnett Susan W |
Combination Approaches For Generating Immune Responses
|
|
CA2591544A1
(en)
*
|
2004-12-15 |
2006-06-22 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
US20100098721A1
(en)
*
|
2006-10-18 |
2010-04-22 |
St. Jude Children's Reseach Hospital |
Methods and compositions for preparing a universal influenza vaccine
|
|
ES2634118T3
(es)
|
2009-02-11 |
2017-09-26 |
The University Of North Carolina At Chapel Hill |
Vectores de virus modificados y métodos para fabricar y utilizar los mismos
|
|
WO2012070974A1
(ru)
*
|
2010-11-22 |
2012-05-31 |
Farber Boris Slavinovich |
Вакцины с повышенной иммуногенностью и способы их получения
|
|
WO2012106363A2
(en)
|
2011-01-31 |
2012-08-09 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
ES2606511T3
(es)
|
2011-04-06 |
2017-03-24 |
Biovaxim Limited |
Composiciones farmacéuticas para prevenir y/o tratar una enfermedad por VIH en seres humanos
|
|
CA2855826A1
(en)
|
2011-11-14 |
2013-05-23 |
Novartis Ag |
Immunogenic complexes of polyanionic carbomers and env polypeptides and methods of manufacture and use thereof
|
|
WO2013126622A1
(en)
|
2012-02-24 |
2013-08-29 |
President And Fellows Of Harvard College |
Methods for displaying polypeptides and uses thereof
|
|
CA3008542C
(en)
*
|
2015-12-15 |
2020-06-02 |
Janssen Vaccines & Prevention B.V. |
Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof
|
|
CN113874078B
(zh)
|
2019-04-05 |
2025-05-06 |
Tauc3生物制品有限公司 |
抗tauc3抗体及其应用
|
|
IT202100000569A1
(it)
*
|
2021-01-14 |
2022-07-14 |
Evobiotech S R L |
Composizione comprendente vescicole extracellulari vegetali ingegnerizzate e suo impiego come vaccino
|